HER-2/neu overexpression and hormone dependency in endometrial cancer: Analysis of cohort and review of literature

Andrea Mariani, Thomas J. Sebo, Jerry A. Katzmann, Darren L. Riehle, Sean Christopher Dowdy, Gary Keeney, Timothy G. Lesnick, Karl C. Podratz

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: Overexpression of HER-2/neu (HER) is associated with unfavorable prognoses in both endometrial and breast cancer. Materials and Methods: To determine whether an association exists between HER expression and markers of hormone dependency in endometrial cancers, we subjected hysterectomy specimens from 125 patients to immunohistochemical staining for HER. HER was visually interpreted as negative/weakly positive (HER-) versus strongly positive (HER+). Estrogen receptor (ER) and progesterone receptor (PR) levels were quantitated on fresh tissue using a dextran-coated charcoal assay. Results: HER+ was observed in 12% of endometrioid tumors and 22% of nonendometnoid tumors (p=0.07). Mean ER and PR levels were 255 fmol/mg and 457 fmol/mg in endometrioid tumors, compared with 74 and 104 in nonendometnoid tumors (p<0.01). Hyperplasia associated with the tumor was related to high levels of both ER and PR (p<0.05), but not with HER expression. Age was significantly related to high levels of ER (p=0.007). Both recurrence and death rates were significantly associated with low levels of ER and PR (p<0.01). Mean ER and PR levels were 270 and 466 fmol/mg, respectively, in HER-tumors, compared with 95 (p=0.14) and 138 fmol/mg (p=0.02) in HER+ tumors. Conclusion: HER overexpression may be an important step in hormone-independent growth and proliferation in a subgroup of endometrial cancers.

Original languageEnglish (US)
Pages (from-to)2921-2928
Number of pages8
JournalAnticancer Research
Volume25
Issue number4
StatePublished - Jul 2005

Fingerprint

Endometrial Neoplasms
Estrogen Receptors
Cohort Studies
Progesterone Receptors
Hormones
Neoplasms
Charcoal
Dextrans
Hysterectomy
Growth Hormone
Hyperplasia
Staining and Labeling
Breast Neoplasms
Recurrence
Mortality

Keywords

  • Endometrial cancer
  • Estrogen receptors
  • HER-2/neu
  • Hormone dependency
  • Progesterone receptors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mariani, A., Sebo, T. J., Katzmann, J. A., Riehle, D. L., Dowdy, S. C., Keeney, G., ... Podratz, K. C. (2005). HER-2/neu overexpression and hormone dependency in endometrial cancer: Analysis of cohort and review of literature. Anticancer Research, 25(4), 2921-2928.

HER-2/neu overexpression and hormone dependency in endometrial cancer : Analysis of cohort and review of literature. / Mariani, Andrea; Sebo, Thomas J.; Katzmann, Jerry A.; Riehle, Darren L.; Dowdy, Sean Christopher; Keeney, Gary; Lesnick, Timothy G.; Podratz, Karl C.

In: Anticancer Research, Vol. 25, No. 4, 07.2005, p. 2921-2928.

Research output: Contribution to journalArticle

Mariani, A, Sebo, TJ, Katzmann, JA, Riehle, DL, Dowdy, SC, Keeney, G, Lesnick, TG & Podratz, KC 2005, 'HER-2/neu overexpression and hormone dependency in endometrial cancer: Analysis of cohort and review of literature', Anticancer Research, vol. 25, no. 4, pp. 2921-2928.
Mariani, Andrea ; Sebo, Thomas J. ; Katzmann, Jerry A. ; Riehle, Darren L. ; Dowdy, Sean Christopher ; Keeney, Gary ; Lesnick, Timothy G. ; Podratz, Karl C. / HER-2/neu overexpression and hormone dependency in endometrial cancer : Analysis of cohort and review of literature. In: Anticancer Research. 2005 ; Vol. 25, No. 4. pp. 2921-2928.
@article{4ace5995ef9f4a9382fe2f67f0b07211,
title = "HER-2/neu overexpression and hormone dependency in endometrial cancer: Analysis of cohort and review of literature",
abstract = "Background: Overexpression of HER-2/neu (HER) is associated with unfavorable prognoses in both endometrial and breast cancer. Materials and Methods: To determine whether an association exists between HER expression and markers of hormone dependency in endometrial cancers, we subjected hysterectomy specimens from 125 patients to immunohistochemical staining for HER. HER was visually interpreted as negative/weakly positive (HER-) versus strongly positive (HER+). Estrogen receptor (ER) and progesterone receptor (PR) levels were quantitated on fresh tissue using a dextran-coated charcoal assay. Results: HER+ was observed in 12{\%} of endometrioid tumors and 22{\%} of nonendometnoid tumors (p=0.07). Mean ER and PR levels were 255 fmol/mg and 457 fmol/mg in endometrioid tumors, compared with 74 and 104 in nonendometnoid tumors (p<0.01). Hyperplasia associated with the tumor was related to high levels of both ER and PR (p<0.05), but not with HER expression. Age was significantly related to high levels of ER (p=0.007). Both recurrence and death rates were significantly associated with low levels of ER and PR (p<0.01). Mean ER and PR levels were 270 and 466 fmol/mg, respectively, in HER-tumors, compared with 95 (p=0.14) and 138 fmol/mg (p=0.02) in HER+ tumors. Conclusion: HER overexpression may be an important step in hormone-independent growth and proliferation in a subgroup of endometrial cancers.",
keywords = "Endometrial cancer, Estrogen receptors, HER-2/neu, Hormone dependency, Progesterone receptors",
author = "Andrea Mariani and Sebo, {Thomas J.} and Katzmann, {Jerry A.} and Riehle, {Darren L.} and Dowdy, {Sean Christopher} and Gary Keeney and Lesnick, {Timothy G.} and Podratz, {Karl C.}",
year = "2005",
month = "7",
language = "English (US)",
volume = "25",
pages = "2921--2928",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4",

}

TY - JOUR

T1 - HER-2/neu overexpression and hormone dependency in endometrial cancer

T2 - Analysis of cohort and review of literature

AU - Mariani, Andrea

AU - Sebo, Thomas J.

AU - Katzmann, Jerry A.

AU - Riehle, Darren L.

AU - Dowdy, Sean Christopher

AU - Keeney, Gary

AU - Lesnick, Timothy G.

AU - Podratz, Karl C.

PY - 2005/7

Y1 - 2005/7

N2 - Background: Overexpression of HER-2/neu (HER) is associated with unfavorable prognoses in both endometrial and breast cancer. Materials and Methods: To determine whether an association exists between HER expression and markers of hormone dependency in endometrial cancers, we subjected hysterectomy specimens from 125 patients to immunohistochemical staining for HER. HER was visually interpreted as negative/weakly positive (HER-) versus strongly positive (HER+). Estrogen receptor (ER) and progesterone receptor (PR) levels were quantitated on fresh tissue using a dextran-coated charcoal assay. Results: HER+ was observed in 12% of endometrioid tumors and 22% of nonendometnoid tumors (p=0.07). Mean ER and PR levels were 255 fmol/mg and 457 fmol/mg in endometrioid tumors, compared with 74 and 104 in nonendometnoid tumors (p<0.01). Hyperplasia associated with the tumor was related to high levels of both ER and PR (p<0.05), but not with HER expression. Age was significantly related to high levels of ER (p=0.007). Both recurrence and death rates were significantly associated with low levels of ER and PR (p<0.01). Mean ER and PR levels were 270 and 466 fmol/mg, respectively, in HER-tumors, compared with 95 (p=0.14) and 138 fmol/mg (p=0.02) in HER+ tumors. Conclusion: HER overexpression may be an important step in hormone-independent growth and proliferation in a subgroup of endometrial cancers.

AB - Background: Overexpression of HER-2/neu (HER) is associated with unfavorable prognoses in both endometrial and breast cancer. Materials and Methods: To determine whether an association exists between HER expression and markers of hormone dependency in endometrial cancers, we subjected hysterectomy specimens from 125 patients to immunohistochemical staining for HER. HER was visually interpreted as negative/weakly positive (HER-) versus strongly positive (HER+). Estrogen receptor (ER) and progesterone receptor (PR) levels were quantitated on fresh tissue using a dextran-coated charcoal assay. Results: HER+ was observed in 12% of endometrioid tumors and 22% of nonendometnoid tumors (p=0.07). Mean ER and PR levels were 255 fmol/mg and 457 fmol/mg in endometrioid tumors, compared with 74 and 104 in nonendometnoid tumors (p<0.01). Hyperplasia associated with the tumor was related to high levels of both ER and PR (p<0.05), but not with HER expression. Age was significantly related to high levels of ER (p=0.007). Both recurrence and death rates were significantly associated with low levels of ER and PR (p<0.01). Mean ER and PR levels were 270 and 466 fmol/mg, respectively, in HER-tumors, compared with 95 (p=0.14) and 138 fmol/mg (p=0.02) in HER+ tumors. Conclusion: HER overexpression may be an important step in hormone-independent growth and proliferation in a subgroup of endometrial cancers.

KW - Endometrial cancer

KW - Estrogen receptors

KW - HER-2/neu

KW - Hormone dependency

KW - Progesterone receptors

UR - http://www.scopus.com/inward/record.url?scp=22944433853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22944433853&partnerID=8YFLogxK

M3 - Article

C2 - 16080545

AN - SCOPUS:22944433853

VL - 25

SP - 2921

EP - 2928

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4

ER -